Compare Johnson & Johnson (JNJ) vs Kroger Co (KR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Kroger Co — how do they compare? Johnson & Johnson trades at $260.87 (market cap $626.09B), while Kroger Co trades at $56.17 (market cap $34.46B). The key difference: Johnson & Johnson is far larger — about 18.2× Kroger Co's market cap, and Kroger Co pays the higher dividend (2.56%). Which is the better fit depends on your goals.
| JNJ | KR | |
|---|---|---|
Market Cap | $626.09B | $34.46B |
Volume | 6,156,228 | — |
Sector | Health | Consumer Staples |
52-Week High | $267.24 | $75.60 |
52-Week Low | $172.78 | $55.53 |
Enterprise Value | $654.37B | $54.56B |
Dividend Yield | 2.06% | 2.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Kroger (KR) trades at $56.15, down 0.58% on the day, reflecting recent market pressure. The stock shows mixed signals with a bearish technical outlook but solid fundamentals including a low P/S ratio of 0.24 and consistent dividend payments. Recent earnings saw a Q1 2026 miss but beats in prior quarters, while analyst consensus remains positive with a $68.25 price target. Cash flow from operations remains strong at $5.79B in 2025, supporting ongoing investments in e-commerce and digital initiatives.
The outlook for KR is cautiously optimistic. Valuation appears reasonable relative to sales, and dividend income provides stability. However, near-term risks include competitive pressures in grocery retail, margin compression from inflation, and technical bearish signals. Investors should weigh strong cash generation against earnings volatility and debt levels that have risen to 30.23% of assets in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Kroger Co
Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.
Read more on KR →
